Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00326-0/fulltext?dgcid=hubspot_update_feature_updatealerts_laneur&utm_campaign=update-laneur&utm_medium=email&_hsenc=p2ANqtz-_EgHjTHRB4pOL582E5JmpIXL1Odns3jZ7c_FBIa47oDyLXkZuhIbBVAqT2TqUAnlyicVxIO7M6hEZ6LPDTQlWbdDdW4Q&_hsmi=332487349&utm_content=332424340&utm_source=hs_email